Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger F Butterworth

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Metabolic Brain Disease|October 23, 2012
Parkinsonism in cirrhosis: pathogenesis and current therapeutic optionsRoger F Butterworth
Frontiers in Neuroscience|March 27, 2023
Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2Roger F Butterworth
Journal of Clinical and Experimental Hepatology|June 5, 2015
Reprint of: Nutrition in the Management of Cirrhosis and its Neurological ComplicationsChantal Bémeur, Roger F Butterworth
Journal of Clinical and Experimental Hepatology|March 11, 2015
Nutrition in the management of cirrhosis and its neurological complicationsChantal Bémeur, Roger F Butterworth
Digestive Diseases (Basel, Switzerland)|July 18, 2018
Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver DiseaseRoger F Butterworth, Ali Canbay
Neurochemistry International|May 22, 2002
The "peripheral-type" benzodiazepine (omega 3) receptor in hyperammonemic disordersPaul Desjardins, Roger F Butterworth
Metabolic Brain Disease|December 6, 2012
Liver-brain proinflammatory signalling in acute liver failure: role in the pathogenesis of hepatic encephalopathy and brain edemaChantal Bémeur, Roger F Butterworth
Metabolic Brain Disease|December 31, 2005
Acute liver failure: a critical appraisal of available animal modelsMireille Bélanger, Roger F Butterworth
Metabolic Brain Disease|December 31, 2005
Role of endogenous benzodiazepine ligands and their GABA-A--associated receptors in hepatic encephalopathySamir Ahboucha, Roger F Butterworth
Neurological Research|January 5, 2008
Mechanisms of brain edema in acute liver failure and impact of novel therapeutic interventionsJavier Vaquero, Roger F Butterworth
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Metabolic Brain Disease|October 23, 2012
Parkinsonism in cirrhosis: pathogenesis and current therapeutic optionsRoger F Butterworth
Frontiers in Neuroscience|March 27, 2023
Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2Roger F Butterworth
Journal of Clinical and Experimental Hepatology|June 5, 2015
Reprint of: Nutrition in the Management of Cirrhosis and its Neurological ComplicationsChantal Bémeur, Roger F Butterworth
Journal of Clinical and Experimental Hepatology|March 11, 2015
Nutrition in the management of cirrhosis and its neurological complicationsChantal Bémeur, Roger F Butterworth
Digestive Diseases (Basel, Switzerland)|July 18, 2018
Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver DiseaseRoger F Butterworth, Ali Canbay
Neurochemistry International|May 22, 2002
The "peripheral-type" benzodiazepine (omega 3) receptor in hyperammonemic disordersPaul Desjardins, Roger F Butterworth
Metabolic Brain Disease|December 6, 2012
Liver-brain proinflammatory signalling in acute liver failure: role in the pathogenesis of hepatic encephalopathy and brain edemaChantal Bémeur, Roger F Butterworth
Metabolic Brain Disease|December 31, 2005
Acute liver failure: a critical appraisal of available animal modelsMireille Bélanger, Roger F Butterworth
Metabolic Brain Disease|December 31, 2005
Role of endogenous benzodiazepine ligands and their GABA-A--associated receptors in hepatic encephalopathySamir Ahboucha, Roger F Butterworth
Neurological Research|January 5, 2008
Mechanisms of brain edema in acute liver failure and impact of novel therapeutic interventionsJavier Vaquero, Roger F Butterworth
Pageof 12